«上一篇/Previous Article|本期目录/Table of Contents|下一篇/Next Article»

《天津医科大学学报》[ISSN:1006-8147/CN:12-1259/R]

卷:

28卷

期数:

2022年01期

页码:

47-52

栏目:

基础研究

出版日期:

2022-01-20

文章信息/Info

Title:

Prognostic value of immune and stromal cell-related genes in tumor microenvironment in lung adenocarcinoma

文章编号:

1006-8147（2022）01-0105-03

作者:

李世雄¹; 2; 耿华²; 徐美林²

（1.天津医科大学胸科临床学院，天津300041 ; 2.天津市胸科医院病理科，天津300300）

Author(s):

LI Shi-xiong¹; 2;  GENG Hua²;  XU Mei-lin²

（1. Clinical College of Chest， Tianjin Medical University， Tianjin 300041，China；2.Department of Pathology， Tianjin Chest Hospital， Tianjin 300300， China）

关键词:

肺腺癌; 癌症基因组图谱; 免疫和基质评分; 预后; 关键基因

Keywords:

lung adenocarcinoma; TCGA; immune/stromal scores; prognosis; hub genes

分类号:

R734.2

DOI:

-

文献标志码:

A

摘要:

目的：鉴别与肺腺癌预后相关的免疫与基质细胞基因。方法：501例肺腺癌基因表达数据来自癌症基因组图谱（TCGA）数据库。肺腺癌样本的免疫和基质评分从ESTIMATE数据库中获取。χ2检验分析基质、免疫评分与患者临床病理特征的相关性。采用t检验以及Cytoscape中的Mcode模块筛选差异表达基因（DEGs）。采用Kaplan-Meier法绘制生存曲线。结果：基质细胞评分与M分期显著相关（χ2=6.391，P=0.011）。免疫评分与M分期（χ2=4.769，P=0.029）、T分期（χ2=11.672，P=0.009）和总生存期（χ2=6.334，P=0.009）显著相关。基于免疫评分的DEGs有262个，基于基质评分的DEGs有391个。基因功能富集分析和蛋白-蛋白相互作用网络分析差异表达基因，富集分析表明，DEGs参与调节免疫应答、抗原结合、免疫应答和受体结合。生存分析表明POSTN（P=0.0181）、PLEK（P=0.0434）、LY86（P=0.0136）、HCK（P=0.0487）对肺腺癌患者具有预后价值。结论：基质细胞相关基因POSTN高表达与患者不良预后相关，免疫细胞相关基因PLEK、LY86、HCK高表达预示患者预后较好。

Abstract:

Objective： To identify prognostic stromal/immune-associated genes in lung adenocarcinoma（LUAD）. Methods: Lung adenocarcinoma gene expression data（501 cases） were obtained from The Cancer Genome Atlas（TCGA）database. Immune and stromal score of lung adenocarcinoma sample were extracted from ESTIMATE database. Chi-square test was used to analyze the correlation between stromal immune score and clinicopathological characteristics of patients. Differentially expressed genes（DEGs） were screened by t test and Mcode module in Cytoscape. Kaplan-Meier method was used to draw the survival curve. Results： Stromal scores were significantly associated with Metastasis stage（χ2=6.391，P=0.011）. Immune scores were significantly associated with Metastasis stage（χ2=4.769，P=0.029）， Tumor stage（χ2=11.672，P=0.009） and overall survival rate（χ2=6.334，P=0.009）. There were 262 differentially expressed genes（DEGs） based on immune scores and 391 DEGs based on stromal scores. Functional enrichment analysis and protein-protein interaction network assessments were employed to analyze differentially expressed genes. Functional enrichment analysis showed that DEGs were involved in regulation of immune response， antigen binding， immune response and receptor binding. Survival analysis showed that POSTN（P=0.0181）， PLEK（P=0.0434），LY86（P=0.0136） and HCK（P=0.0487） had prognostic value in patients with lung adenocarcinoma. Conclusion：High expression of the stromal cell-associated gene POSTN is associated with poor prognosis in patients. High expression of immune cell-related genes PLEK， LY86 and HCK predicted a good prognosis.

参考文献/References:

[1] CHEN J，YANG H，TEO A S M，et al. Genomic landscape of lung adenocarcinoma in East Asians[J]. Nat Genet，2020，52（2）：177-186.
[2] XU X，HUANG Z，ZHENG L，et al. The efficacy and safety of anti-PD-1/PD-L1 antibodies combined with chemotherapy or CTLA4 antibody as a first-line treatment for advanced lung cancer [J]. Int J Cancer，2018，142（11）：2344-2354.
[3] WU Q，WANG L，WEI H，et al. Integration of multiple key molecules in lung adenocarcinoma identifies prognostic and immunotherapeutic relevant gene signatures [J]. Int Immunopharmacol，2020，83（9）：106477-106490.
[4] DARRAGH L B，OWEIDA A J，KARAM S D. Overcoming resistance to combination radiation-immunotherapy：a focus on contributing pathways within the tumor microenvironment[J]. Front Immunol， 2018，31（9）：3154-3166.
[5] WANG Z，XU H，ZHU L，et al. Establishment and evaluation of a 6-gene survival risk assessment model related to lung adenocarcinoma microenvironment[J]. Biomed Res Int，2020，10（3）：1155-1168.
[6] YOSHIHARA K，SHAHMORADGOLI M，MARTINEZ E，et al. Inferring tumour purity and stromal and immune cell admixture from expression data[J]. Nat Commun，2013，4（1）：2612-2623.
[7] WANG H，WU X，CHEN Y. Stromal-immune score-based gene signature：a prognosis stratification tool in gastric cancer[J]. Front Oncol，2019，12（9）：1212-1226.
[8] CHEN C，CHEN H，ZHANG Y，et al. TBtools：an integrative tool kit developed for interactive analyses of big biological data[J]. Mol Plant，2020，13（8）: 1194-1202.
[9] SZKLARCZYK D，GABLE A L，LYON D，et al. STRING v11：protein-protein association networks with increased coverage，supporting functional discovery in genome-wide experimental datasets[J]. Nucleic Acids Res，2019，47（D1）：D607-D613.
[10] DONCHEVA N T，MORRIS J H，GORODKIN J，et al. Cytoscape stringapp：network analysis and visualization of proteomics data[J]. J Proteome Res，2019，18（2）：623-632.
[11] HUANG DA W，SHERMAN B T，LEMPICKI R A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources [J]. Nat Protoc，2009，4（1）：44-57.
[12] PATEL H，NILENDU P，JAHAGIRDAR D，et al. Modulating secreted components of tumor microenvironment：a masterstroke in tumor therapeutics [J]. Cancer Biol Ther，2018，19（1）：3-12.
[13] WANG Z，CHEN X. Establishment and validation of an immune-associated signature in lung adenocarcinoma[J]. Int Immunopharmacol，2020，88（11）：106867-106877.
[14] HUANG J，LI J，ZHENG S，et al. Tumor microenvironment characterization identifies two lung adenocarcinoma subtypes with specific immune and metabolic state[J]. Cancer Sci，2020，111（6）：1876-1886.
[15] XU Z Y，ZHAO M，CHEN W，et al. Analysis of prognostic genes in the tumor microenvironment of lung adenocarcinoma[J]. Peer J，2020， 8（7）：e9530-e9549.
[16] LUNDMARK A，DAVANIAN H，BAGE T，et al. Transcriptome analysis reveals mucin 4 to be highly associated with periodontitis and identifies pleckstrin as a link to systemic diseases[J]. Sci Rep，2015， 5（1）：18475-18488.
[17] PAN H，ZHANG G，ZHANG L，et al. MD-1 deficiency attenuates dextran sodium sulfate（DSS）-induced colitis through modulating the function of colonic lamina propria dendritic cells[J]. Mol Immunol，2016，75（7）：1-10.
[18] POH A R，LOVE C G，MASSON F，et al. Inhibition of hematopoietic cell kinase activity suppresses myeloid cell-mediated colon cancer progression [J]. Cancer Cell，2017，31（4）：563-575.
[19] ZHONG H，LI X，ZHANG J，et al. Overexpression of periostin is positively associated with gastric cancer metastasis through promoting tumor metastasis and invasion[J]. J Cell Biochem，2019，120（6）：9927-9935.
[20] HAN X，WANG Q，WANG Y，et al. Long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1/microRNA-202-3p/periostin axis modulates invasion and epithelial-mesenchymal transition in human cervical cancer[J]. J Cell Physiol，2019，234（8）：14170-14180.
[21] DUMA N，SANTANA-DAVILA R，MOLINA J R. Non-small cell lung cancer：epidemiology，screening，diagnosis，and treatment[J]. Mayo Clin Proc，2019，94（8）：1623-1640.
[22] SHROFF G S，DE GROOT P M，PAPADIMITRAKOPOULOU V A，et al. targeted therapy and immunotherapy in the treatment of non-small cell lung cancer[J]. Radiol Clin North Am，2018，56（3）：485-495.

相似文献/References:

[1]林高阳,徐 克.氯化锂调控人肺腺癌A549细胞增殖侵袭转移的体外研究[J].天津医科大学学报,2015,21(01):9.
　LIN Gao-yang,XU Ke.Investigation of the effect of lithium chloride on proliferation and metastasis potential of human lung adenocarcinoma A549 cells in vitro[J].Journal of Tianjin Medical University,2015,21(01):9.
[2]赵青春,韦 森,张洪兵,等.分析第6版和第7版TNM分期在肺腺癌患者中的差异[J].天津医科大学学报,2015,21(05):432.
[3]高周勇,张文成,王广舜.基于TCGA数据库分析GTSE1基因在肺腺癌中的表达及意义[J].天津医科大学学报,2021,27(03):274.
　GAO Zhou-yong,ZHANG Wen-cheng,WANG Guang-shun.Expression and significance of GTSE1 gene in lung adenocarcinoma based on TCGA database[J].Journal of Tianjin Medical University,2021,27(01):274.
[4]骆源,徐启飞,吕泽政,等.三维ResNet 网络预测肺腺癌结节亚型的效能及其 稳定性[J].天津医科大学学报,2022,28(03):295.
　LUO Yuan,XU Qi-fei,LYU Ze-zheng,et al.Efficacy and stability of 3D ResNet for predicting nodule subtypes in lung adenocarcinoma[J].Journal of Tianjin Medical University,2022,28(01):295.
[5]马梦楚,任媛媛,刘欣.肺腺癌细胞中PRDM5抑癌作用的分子机制初探[J].天津医科大学学报,2022,28(04):360.
　MA Meng-chu,REN Yuan-yuan,LIU Xin.Preliminary study on the molecular mechanism of PRDM5 suppression in lung adenocarcinoma[J].Journal of Tianjin Medical University,2022,28(01):360.

备注/Memo

备注/Memo:

作者简介 李世雄（1994-），男，硕士在读，研究方向：肺癌分子病理学；通信作者：徐美林，E-mail：meilinxugh2017@163.com。

常用功能

更新日期/Last Update: 2022-01-20